130 related articles for article (PubMed ID: 21512673)
1. Bilateral renal metastases from papillary thyroid carcinoma on post 131I treatment scan: flip-flop sign, radioiodine SPET, 18F-FDG PET, CECT and histopathological correlation.
Borde C; Basu S; Kand P; Arya S; Shet T
Hell J Nucl Med; 2011; 14(1):72-3. PubMed ID: 21512673
[No Abstract] [Full Text] [Related]
2. Diffuse pulmonary metastases with negative ¹⁸FDG positron emission tomography/computed tomography and positive post-radioiodine therapy scan of papillary thyroid cancer.
Lin YS; Liang ZY; Qiu LH; Cheng X
Chin Med J (Engl); 2012 Jan; 125(1):153-6. PubMed ID: 22340484
[TBL] [Abstract][Full Text] [Related]
3. Unusual case of adrenal and renal metastases from papillary carcinoma of thyroid.
Malhotra G; Upadhye TS; Sridhar E; Asopa RV; Garde PS; Gawde S; Rangarajan V
Clin Nucl Med; 2010 Sep; 35(9):731-6. PubMed ID: 20706057
[TBL] [Abstract][Full Text] [Related]
4. Iodine-131 SPET/CT and 18F-FDG PET/CT for the identification and localization of mediastinal lymph node metastases from differentiated thyroid carcinoma.
Xu YH; Shen CT; Xue YL; Qiu ZL; Luo QY
Hell J Nucl Med; 2013; 16(3):199-203. PubMed ID: 24251307
[TBL] [Abstract][Full Text] [Related]
5. Axillary lymph node metastasis of papillary thyroid carcinoma detected by FDG PET/CT in a thyroglobulin-positive patient with negative whole-body 131I scan.
Elboga U; Kalender E; Yilmaz M; Celen YZ; Aktolun C
Clin Nucl Med; 2012 Nov; 37(11):1120-2. PubMed ID: 22996245
[TBL] [Abstract][Full Text] [Related]
6. Detection of intraluminal tracheal metastasis of thyroid papillary carcinoma by 18F-FDG PET/CT.
Ozkan E; Araz M; Soydal C; Kucuk NO; Ibis E
Clin Nucl Med; 2012 Jun; 37(6):e160-1. PubMed ID: 22614217
[TBL] [Abstract][Full Text] [Related]
7. Extensive lymph node metastases found by (18)F-FDG-PET/CT in a patient with diffuse sclerosing variant of papillary thyroid carcinoma.
Xu YH; Song HJ; Qiu ZL; Luo QY
Hell J Nucl Med; 2011; 14(2):188-9. PubMed ID: 21761030
[No Abstract] [Full Text] [Related]
8. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
Iwata M; Kasagi K; Misaki T; Matsumoto K; Iida Y; Ishimori T; Nakamoto Y; Higashi T; Saga T; Konishi J
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):491-8. PubMed ID: 14666387
[TBL] [Abstract][Full Text] [Related]
9. Correlation of 18F-FDG PET/CT findings with histopathological results in differentiated thyroid cancer patients who have increased thyroglobulin or antithyroglobulin antibody levels and negative 131I whole-body scan results.
Ozkan E; Aras G; Kucuk NO
Clin Nucl Med; 2013 May; 38(5):326-31. PubMed ID: 23486319
[TBL] [Abstract][Full Text] [Related]
10. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Lind P; Kohlfürst S
Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous uptake of I-131 and F-18 FDG by a renal metastasis of thyroid papillary cancer.
Oh JR; Lim JH; Jeong SY; Heo SH; Chong A; Min JJ
Clin Nucl Med; 2011 Sep; 36(9):798-9. PubMed ID: 21825854
[No Abstract] [Full Text] [Related]
12. Asymptomatic solitary cerebral metastasis from papillary carcinoma thyroid: 131I SPECT/CT for accurate staging.
Jain TK; Karunanithi S; Sharma P; Vijay MK; Ballal S; Bal C
Clin Nucl Med; 2014 Nov; 39(11):977-9. PubMed ID: 24566406
[TBL] [Abstract][Full Text] [Related]
13. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
[TBL] [Abstract][Full Text] [Related]
14. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
Salvatore B; Paone G; Klain M; Storto G; Nicolai E; D'Amico D; Della Morte AM; Pace L; Salvatore M
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):2-8. PubMed ID: 17538522
[TBL] [Abstract][Full Text] [Related]
15. Impact of patient age on the iodine/FDG "flip-flop" phenomenon in lung metastasis from thyroid cancer.
Isoda T; BaBa S; Maruoka Y; Kitamura Y; Tahara K; Sasaki M; Honda H
Ann Nucl Med; 2016 Oct; 30(8):518-24. PubMed ID: 27380042
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG PET/CT demonstration of a liver metastasis in a patient with papillary thyroid cancer.
Mosci C; McDougall IR; Jeffrey RB; Iagaru A
Clin Nucl Med; 2012 Sep; 37(9):e234-6. PubMed ID: 22889801
[TBL] [Abstract][Full Text] [Related]
17. Renal metastases from thyroid carcinoma.
Malhotra G; Asopa R; Rajan MG
Thyroid; 2010 Nov; 20(11):1321; author reply 321-2. PubMed ID: 21062198
[No Abstract] [Full Text] [Related]
18. Is it practical and cost effective to detect differentiated thyroid carcinoma metastases by (18)F-FDG PET/CT, by (18)F-FDG SPET/CT or by (131)I SPET/CT?
He X; Wang X; Yu J; Ma C
Hell J Nucl Med; 2015; 18(1):2-4. PubMed ID: 25679071
[TBL] [Abstract][Full Text] [Related]
19. Intravenous Tumor Thrombus From Papillary Carcinoma of Thyroid Demonstrated by 18F-FDG PET/CT.
Wang Y; Jiang L; Zhang X; Xu Y; Liu B
Clin Nucl Med; 2022 Jun; 47(6):541-542. PubMed ID: 35025802
[TBL] [Abstract][Full Text] [Related]
20. A proposition for the use of radioiodine in WDTC management.
Bourgeois P
J Nucl Med; 2009 Feb; 50(2):328-9; author reply 329-30. PubMed ID: 19164221
[No Abstract] [Full Text] [Related]
[Next] [New Search]
